下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Norman Payson Sells 6,618 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
诺曼·佩森出售6,618股宝洁公司(纳斯达克代码:PGNY)股票

Defense World ·  {{timeTz}}

Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Norman Payson sold 6,618 shares of the firm's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $32.27, for a total value of $213,562.86. Following the transaction, the director now directly owns 411,412 shares of the company's stock, valued at approximately $13,276,265.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

纳斯达克:PGNY-GET评级)董事诺曼·佩森在8月3日周三的一笔交易中出售了6618股该公司股票。这些股票的平均价格为32.27美元,总价值为213,562.86美元。交易完成后,董事现在直接持有该公司411,412股股票,价值约13,276,265.24美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,这份文件可以在美国证券交易委员会的网站上找到。

Norman Payson also recently made the following trade(s):

诺曼·佩森最近还进行了以下交易:

Get
到达
Progyny
孕期
alerts:
警报:
  • On Wednesday, July 20th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $33.40, for a total value of $221,041.20.
  • On Wednesday, July 6th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $29.38, for a total value of $194,436.84.
  • On Wednesday, June 22nd, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $27.35, for a total value of $181,002.30.
  • On Wednesday, May 25th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $32.09, for a total value of $212,371.62.
  • On Wednesday, May 11th, Norman Payson sold 6,618 shares of Progyny stock. The stock was sold at an average price of $33.45, for a total value of $221,372.10.
  • 7月20日,星期三,诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为33.40美元,总价值为221,041.20美元。
  • 7月6日,星期三,诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为29.38美元,总价值为194,436.84美元。
  • 6月22日,星期三,诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为27.35美元,总价值为181,002.30美元。
  • 5月25日,星期三,诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为32.09美元,总价值为212,371.62美元。
  • 5月11日,星期三,诺曼·佩森出售了6,618股Progyny股票。这只股票的平均售价为33.45美元,总价值为221,372.10美元。

Progyny Price Performance

孕期性价比

PGNY opened at $41.15 on Friday. The stock has a 50-day moving average price of $30.23 and a 200-day moving average price of $37.32. The firm has a market cap of $3.78 billion, a PE ratio of 89.46, a P/E/G ratio of 15.71 and a beta of 1.85. Progyny, Inc. has a 1 year low of $25.67 and a 1 year high of $68.32.

上周五,纽约商品交易所开盘报41.15美元。该股的50日移动均线价格为30.23美元,200日移动均线价格为37.32美元。该公司市值为37.8亿美元,市盈率为89.46倍,市盈率为15.71倍,贝塔系数为1.85。Progyny,Inc.的一年低点为25.67美元,一年高位为68.32美元。

Progyny (NASDAQ:PGNY – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.04. The firm had revenue of $195.00 million during the quarter, compared to analyst estimates of $190.51 million. Progyny had a return on equity of 18.11% and a net margin of 7.39%. Progyny's quarterly revenue was up 51.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.19 EPS. As a group, sell-side analysts anticipate that Progyny, Inc. will post 0.09 EPS for the current year.
纳斯达克(股票代码:PGNY-GET Rating)最近一次公布季度收益是在8月4日星期四。该公司公布本季度每股收益(EPS)为0.09美元,比普遍预期的0.05美元高出0.04美元。该公司本季度营收为1.95亿美元,而分析师预期为1.9051亿美元。Progyny的股本回报率为18.11%,净利润率为7.39%。与去年同期相比,Progyny的季度收入增长了51.5%。去年同期,该公司每股收益为0.19美元。卖方分析师预计,作为一个整体,Progyny,Inc.本年度每股收益将为0.09美元。

Hedge Funds Weigh In On Progyny

对冲基金对Progyny的看法

Several large investors have recently modified their holdings of PGNY. National Bank of Canada FI purchased a new position in shares of Progyny in the 2nd quarter worth about $29,000. First Horizon Advisors Inc. raised its position in Progyny by 1,469.4% in the 4th quarter. First Horizon Advisors Inc. now owns 769 shares of the company's stock worth $38,000 after buying an additional 720 shares during the last quarter. Fifth Third Bancorp raised its position in Progyny by 1,532.4% in the 4th quarter. Fifth Third Bancorp now owns 1,208 shares of the company's stock worth $61,000 after buying an additional 1,134 shares during the last quarter. Steward Partners Investment Advisory LLC raised its position in Progyny by 44.8% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,209 shares of the company's stock worth $61,000 after buying an additional 374 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new position in Progyny in the 1st quarter worth about $62,000. Hedge funds and other institutional investors own 82.51% of the company's stock.

几家大型投资者最近调整了对PGNY的持股。加拿大国民银行FI在第二季度购买了Progyny的新头寸,价值约29,000美元。First Horizon Advisors Inc.在第四季度将其在Progyny的头寸提高了1,469.4%。First Horizon Advisors Inc.现在持有该公司769股股票,价值3.8万美元,该公司在上个季度又购买了720股。Five Third Bancorp在第四季度将其在Progyny的头寸提高了1,532.4%。Five Third Bancorp现在拥有1,208股该公司股票,价值61,000美元,在上个季度又购买了1,134股。Steward Partners Investment Consulting LLC在第四季度将其在Progyny的头寸提高了44.8%。Steward Partners Investment Consulting LLC现在拥有1,209股该公司股票,价值61,000美元,上个季度又购买了374股。最后,Lazard Asset Management LLC在第一季度购买了Progyny的一个新头寸,价值约62,000美元。对冲基金和其他机构投资者持有该公司82.51%的股票。

About Progyny

关于Progyny

(Get Rating)

(获取评级)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Progyny,Inc.是一家福利管理公司,专门为美国雇主提供生育和家庭建设福利解决方案。其生育福利解决方案包括差异化福利计划设计、个性化礼宾式会员支持服务和有选择的生育专家网络。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Progyny (PGNY)
  • MarketBeat: Week in Review 8/1 – 8/5
  • How to Use High Beta Stocks to Maximize Your Investing Profits
  • Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
  • Beyond Meat Is Not Beyond Hope, And It's Cheap
  • Why Apple Could Be At All-Time Highs By Year End
  • 免费获取StockNews.com关于Progyny的研究报告(PGNY)
  • MarketBeat:回顾中的一周8/1-8/5
  • 如何利用高贝塔系数股票最大化你的投资利润
  • 克罗诺斯集团(Cronos Group Inc.)营收上升,是时候收购了吗?
  • Beyond Meat不是没有希望,而且它很便宜
  • 苹果为何可能在年底创下历史新高

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.

接受Progyny Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Progyny和相关公司的最新新闻和分析师评级的每日简要摘要。

本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。

回到顶部